In VivoQubit Pharmaceuticals, a biotech that employs quantum physics and artificial intelligence for drug discovery, and Sorbonne University have launched a quantum AI model that could reduce drug synthesis
ScripBig multibillion-dollar merger-and-acquisition deals have been few and far between in 2025, but that does not mean dealmaking has come to a standstill. In fact, based on Scrip ’s interviews and obser
Pink SheetThe European Medicines Agency is exploring how to help drug companies develop treatments for systemic sclerosis (SSc), a rare connective tissue disorder associated with high morbidity and mortality bu
Pink SheetThe European Medicines Agency has begun reviewing a new batch of products for potential pan-EU marketing approval, including LIB Therapeutics’ lerodalcibep for treating primary hypercholesterolemia or